Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LPCAT3 Is Transcriptionally Regulated by YAP/ZEB/EP300 and Collaborates with ACSL4 and YAP to Determine Ferroptosis Sensitivity
Jiangtao Cui, Yikun Wang, Xiaoting Tian, et al.
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 7-9, pp. 491-511
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

FSP1: a key regulator of ferroptosis
Wentao Li, Longteng Liang, Siyi Liu, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 9, pp. 753-764
Open Access | Times Cited: 110
Ferroptosis in health and disease
Carsten Berndt, Hamed Alborzinia, Vera Skafar Amen, et al.
Redox Biology (2024) Vol. 75, pp. 103211-103211
Open Access | Times Cited: 69
Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Lin Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
Mechanisms and regulations of ferroptosis
Xu-Dong Zhang, Zhongyuan Liu, Mao-Sen Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 54
The mechanisms of ferroptosis and its role in atherosclerosis
Xi Xu, Xiaodan Xu, Mengqing Ma, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116112-116112
Open Access | Times Cited: 41
Ferroptotic therapy in cancer: benefits, side effects, and risks
Jiandong Diao, Yuanyuan Jia, Enyong Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 31
Antioxidant Systems as Modulators of Ferroptosis: Focus on Transcription Factors
Carolina Punziano, Silvia Trombetti, Elena Cesaro, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 298-298
Open Access | Times Cited: 17
Regulation of Ferroptosis in Lung Adenocarcinoma
Xiangyun Wei, Xiaohe Li, Shuming Hu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14614-14614
Open Access | Times Cited: 32
FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications
Ran Gao, Jinge Wang, Jingjing Huang, et al.
APOPTOSIS (2024) Vol. 29, Iss. 7-8, pp. 1019-1037
Closed Access | Times Cited: 15
Adverse effects of ferroptotic therapy: mechanisms and management
Jiao Liu, Rui Kang, Daolin Tang
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 417-429
Closed Access | Times Cited: 14
Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-γ-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors
Qian Tao, Nian Liu, Jie Wu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 3, pp. e008554-e008554
Open Access | Times Cited: 13
Parkin inhibits iron overload-induced cardiomyocyte ferroptosis by ubiquitinating ACSL4 and modulating PUFA-phospholipids metabolism
Dandan Xiao, Wenguang Chang, Xiang Ao, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access | Times Cited: 1
Ferroptosis and hearing loss: from molecular mechanisms to therapeutic interventions
Xiaozhen Lv, Chenyi Yang, Xianying Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Ferroptosis as an emerging target in rheumatoid arthritis
Hui Zhao, Cheng Tang, Miao Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
The potential roles of HIF-1α in epithelial-mesenchymal transition and ferroptosis in tumor cells
Zhongjun Shen, Na Yu, Yanfeng Zhang, et al.
Cellular Signalling (2024) Vol. 122, pp. 111345-111345
Open Access | Times Cited: 8
Theoretical Framework and Emerging Challenges of Lipid Metabolism in Cancer
Qiuying Gu, Yuan Wang, Ping Yi, et al.
Seminars in Cancer Biology (2024)
Open Access | Times Cited: 5
Ferroptosis: An important mechanism of disease mediated by the gut-liver-brain axis
Xin‐Xin Yu, Shihao Wang, Zhongjie Ji, et al.
Life Sciences (2024) Vol. 347, pp. 122650-122650
Closed Access | Times Cited: 4
Contemporary insights and prospects on ferroptosis in rheumatoid arthritis management
Hongyu Zhao, Qiumei Dong, Hao Hua, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
The critical role of ferroptosis in virus-associated hematologic malignancies and its potential value in antiviral-antitumor therapy
Miao Miao, Yue‐Lei Chen, Xuehan Wang, et al.
Virulence (2025) Vol. 16, Iss. 1
Open Access
Nanomaterials as Modulators of Non-apoptotic Regulated Cell Death Modes: Novel Options in Cancer Treatment
Anton Tkachenko
Interdisciplinary cancer research (2025)
Closed Access
Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Feng Zhang, et al.
Bone Research (2025) Vol. 13, Iss. 1
Open Access
Epithelial-mesenchymal Transition Promotes Metabolic Reprogramming to Suppress Ferroptosis
Wenzheng Guo, Zhibing Duan, Jingjing Wu, et al.
Seminars in Cancer Biology (2025)
Closed Access
Unveiling the therapeutic potential of ferroptosis in lung cancer: a comprehensive bibliometric analysis and future therapeutic insights
Wenwei Song, P. Sun, Tongzhen Zhao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Cell Death Mechanisms in Mycobacterium abscessus Infection: A Double-Edged Sword
Rhana Berto da Silva Prata, Roberta Olmo Pinheiro
Pathogens (2025) Vol. 14, Iss. 4, pp. 391-391
Open Access
Bulk RNA-seq conjoined with ScRNA-seq analysis reveals the molecular characteristics of nucleus pulposus cell ferroptosis in rat aging intervertebral discs
Shipeng Chen, Jiawei Fu, Jiang Long, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top